Education
About Us
Working with TipRanks
Follow Us
Quantum-Si Incorporated (QSI)
:QSI
QSI Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.61 - $5.77
Previous CloseN/A
Volume35.47M
Average Volume (3M)7.19M
Market Cap
$228.93M
Enterprise Value-$56.89M
Total Cash (Recent Filing)$49.24M
Total Debt (Recent Filing)$12.95M
Price to Earnings (P/E)―
Beta2.90
Next Earnings
May 08, 2025EPS Estimate
-0.15Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.70
Shares Outstanding163,207,090
10 Day Avg. Volume3,812,777
30 Day Avg. Volume7,188,310
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)87.14
Price to Cash Flow (P/CF)-2.90
P/FCF Ratio0.00
Enterprise Value/Market Cap-0.25
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit-35.56
Enterprise Value/Ebitda0.54
Forecast
1Y Price Target
$3.38Price Target Upside170.40% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering3
---
Quantum-Si News
PremiumCompany Announcements
Quantum-Si Updates Corporate Strategy in Proteomics
PremiumCompany Announcements
Quantum-Si’s Earnings Call: Growth and Strategic Moves
PremiumCompany Announcements
Quantum-Si Reports Milestone Revenue and Strategic Growth
---
Bulls Say, Bears Say
Bulls Say
Market ExpansionThe company emphasized expansion into the international market with 18 international distribution partners to date, which could provide opportunities for revenue growth.
Partnerships And DistributionThe company's North American distribution agreement with Avantor is expected to significantly expand the number of sales representatives engaging and training potential customers.
Product Launch And InnovationQuantum-Si plans to launch a V4 sequencing kit with improved features, effectively expanding proteome coverage.
Bears Say
Adoption And PerformanceDecreasing price target to $1.00 reflects updated adoption assumptions for protein sequencing.
Funding UncertaintyUncertainty regarding NIH funding could continue to impact the academic research market.
Market Penetration ChallengesIt may take significant time before QSI can penetrate the protein sequencing opportunity.
---
Ownership Overview
26.17% Insiders
5.44% Mutual Funds
14.09% Other Institutional Investors
42.61% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
QSI FAQ
What was Quantum-Si Incorporated’s price range in the past 12 months?
Quantum-Si Incorporated lowest stock price was $0.61 and its highest was $5.77 in the past 12 months.
What is Quantum-Si Incorporated’s market cap?
Quantum-Si Incorporated’s market cap is $228.93M.
When is Quantum-Si Incorporated’s upcoming earnings report date?
Quantum-Si Incorporated’s upcoming earnings report date is May 08, 2025 which is in 24 days.
How were Quantum-Si Incorporated’s earnings last quarter?
Quantum-Si Incorporated released its earnings results on Mar 03, 2025. The company reported -$0.23 earnings per share for the quarter, missing the consensus estimate of -$0.18 by -$0.05.
Is Quantum-Si Incorporated overvalued?
According to Wall Street analysts Quantum-Si Incorporated’s price is currently Undervalued.
Does Quantum-Si Incorporated pay dividends?
Quantum-Si Incorporated does not currently pay dividends.
What is Quantum-Si Incorporated’s EPS estimate?
Quantum-Si Incorporated’s EPS estimate is -0.15.
How many shares outstanding does Quantum-Si Incorporated have?
Quantum-Si Incorporated has 163,207,090 shares outstanding.
What happened to Quantum-Si Incorporated’s price movement after its last earnings report?
Quantum-Si Incorporated reported an EPS of -$0.23 in its last earnings report, missing expectations of -$0.18. Following the earnings report the stock price went up 6.154%.
Which hedge fund is a major shareholder of Quantum-Si Incorporated?
Currently, no hedge funds are holding shares in QSI
---
Quantum-Si Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$3.38 (170.40% Upside)
$3.38 (170.40% Upside)
Blogger Sentiment
Neutral
QSI Sentiment 50%
Sector Average 69%
Sector Average 69%
Hedge Fund Trend
Decreased
By 3.0M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $57.3K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Negative
Last 7 Days ▼ 1.0%
Last 30 Days >0.1%
Last 30 Days >0.1%
News Sentiment
Neutral
Bullish news 59%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-31.31%
12-Months-Change
Fundamentals
Return on Equity
-41.48%
Trailing 12-Months
Asset Growth
-16.89%
Trailing 12-Months
Company Description
Quantum-Si Incorporated
Quantum-Si (QSI) is a biotechnology company focused on revolutionizing the field of proteomics through its proprietary semiconductor chip-based technology. The company operates within the life sciences sector, providing innovative tools for protein sequencing and analysis. Quantum-Si's core products include next-generation protein sequencing platforms designed to deliver precision and scalability in protein identification and quantification, catering to researchers and clinicians seeking to advance their understanding of proteomics and its applications in healthcare and scientific research.
---
QSI Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
Quantum-Si reported strong revenue growth and expanded its customer base and distribution channels in 2024. Significant scientific advancements were made, with multiple publications and new product launches. However, challenges such as NIH funding uncertainty and long sales cycles remain. Despite these challenges, the company maintains a strong financial position and strategic partnerships, providing confidence moving forward.Read More>---
QSI Stock 12 Month Forecast
Average Price Target
$3.38
▲(170.40% Upside)
Technical Analysis
Nautilus Biotechnolgy
―
Foghorn Therapeutics
―
Atea Pharmaceuticals
―
Compass Therapeutics
―
Seer
―
Best Analysts Covering QSI
1 Year
1 Year Success Rate
2/7 ratings generated profit
1 Year Average Return
-1.33%
reiterated a buy rating last month
Copying Swayampakula Ramakanth's trades and holding each position for 1 Year would result in 28.57% of your transactions generating a profit, with an average return of -1.33% per trade.
---